Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey

International Journal of Cardiology
Raffaele GriffoICAROS investigators

Abstract

Secondary prevention is a priority after coronary revascularization. We investigate the impact of a cardiac rehabilitation (CR) program on lifestyle, risk factors and medication modifications and analyze predictors of poor behavioral changes and events in patients after coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI). Multicenter (n=62), prospective, longitudinal survey in post-CABG or -PCI consecutive patients after a comprehensive CR program. Cardiac risk factors, lifestyle habits, medication and 1 year cardiovascular events were collected. Logistic regression analyzed the association between risk factors, events and predictors of non-adherence to treatment and lifestyle. At 1 year, of the 1262 patients (66 ± 10 years, CABG 69%, PCI 31%), 94% were taking antiplatelet agents (vs. 91.8% at CR admission and 91.7% at CR discharge, p=ns), 87% statins (vs. 67.5%, p<.0001, and 86.3%, p=ns), 80.7% beta-blockers (vs. 67.4%, p<.0001, and 88.8%, p=ns), and 81.1% ACE inhibitors (vs. 57.5% p<.0001, and 77.7%, p=ns). 89.9% of the patients showed good adherence to treatment, 72% adhered to diet and 51% to exercise recommendations; 74% of smokers stopped smoking. Younger age was predictive of smoking resump...Continue Reading

References

Jul 9, 2004·The Annals of Pharmacotherapy·Stephen J ShalanskyAndrew P Ignaszewski
Nov 3, 2005·Annals of Internal Medicine·Alexander M ClarkFinlay A McAlister
Sep 27, 2006·Archives of Internal Medicine·P Michael HoJohn S Rumsfeld
Jun 30, 2009·The American Journal of Medicine·Nilay D ShahVéronique L Roger
Dec 3, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Massimo Francesco PiepoliUNKNOWN Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation

❮ Previous
Next ❯

Citations

Oct 23, 2013·Internal and Emergency Medicine·Marco AmbrosettiCesare Greco
Nov 27, 2015·Tobacco Induced Diseases·Venetia NotaraUNKNOWN GREECS Study Investigators, Greece
Jan 1, 2014·International Journal of Cardiology·Marco AmbrosettiUNKNOWN THINKPAD investigators
Dec 4, 2012·International Journal of Cardiology·Sait DemirkolMurat Karaman
Jun 19, 2016·British Journal of Health Psychology·Sara GostoliChiara Rafanelli
Jul 6, 2016·International Journal of Cardiology·Lina Badimon, Judit Cubedo
Mar 21, 2017·Journal of Cardiovascular Medicine·Patrizia MarasCatherine Klersy
Feb 14, 2015·Circulation·Alexander KulikUNKNOWN American Heart Association Council on Cardiovascular Surgery and Anesthesia
Oct 18, 2014·Journal of Cardiovascular Medicine·Luigi PinnarelliCarlo A Perucci
May 28, 2020·Journal of the American College of Nutrition·Ulla Bach LaursenMogens Lytken Larsen
May 31, 2014·The Physician and Sportsmedicine·Garrett N CoyanJames L Vacek
Jun 6, 2018·European Heart Journal Supplements : Journal of the European Society of Cardiology·Michele Massimo GuliziaUNKNOWN Faculty for approval of the Consensus Document
Dec 24, 2019·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Jonathan YapKhung K Yeo
Oct 19, 2013·Einstein·Vanessa MairLuciana Diniz Nagem Janot de Matos
May 1, 2015·Journal of Cardiovascular Pharmacology and Therapeutics·Stefania MaraziaMichele Di Mauro
Apr 22, 2018·Aging Clinical and Experimental Research·Yong Hwan Kim, Wi-Young So
Jul 29, 2017·European Heart Journal Supplements : Journal of the European Society of Cardiology·Michele Massimo GuliziaAttilio Maseri
Nov 15, 2019·Journal of Exercise Rehabilitation·José Manuel Afonso Moreira, Eugénia Nunes Grilo
Dec 2, 2020·The Thoracic and Cardiovascular Surgeon·Dror B LevinerErez Sharoni
Mar 30, 2021·Nursing in Critical Care·Silvio SimeoneRosaria Alvaro
Jun 12, 2021·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·T VromenH M Kemps
Oct 13, 2021·Annales de cardiologie et d'angéiologie·Bruno PavyUNKNOWN group of exercise rehabilitation sport prevention (GERSP) of the French Society of Cardiology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.